Treatment of cancer cells with vitamin D3 induced death <i>a.</i> by Vidya G. Bettada (22208808)

Fig 7 - by Kalman F. Szucs (19353218)

Vaginal impedance values measured with the estrus cycle monitor before and after 7 days of cetrorelix treatment (Fig 2). by Kalman F. Szucs (19353218)

Maximum values of power spectrum density in 2 different groups of rats detected by in vivo smooth muscle electromyography (Fig 4). by Kalman F. Szucs (19353218)

The average radiant efficiency values in equally sized regions of interest of the non-pregnant uterus in the control and cetrorelix treated rats (Fig 6). by Kalman F. Szucs (19353218)

Silencing expression of Foxo1 increases Na_V1.5 expression. by Weike Mao (181121)

“…<p>Western blots showed decrease of Foxo1 protein by 50 MOI (n = 4) and 100 MOI Adv-Foxo1 RNAi (n = 4) increased Na_V1.5 protein in HL-1 cells in comparison with 100 MOI Adv-scramble RNAi (n = 4) (A) and this inhibition reached the significant difference (*p<0.05) at 100 MOI Adv-Foxo1-RNAi (C). …”

Insufficient disulfide bond formation results in a decrease in alkaline phosphatase activity and accumulation of the reduced form of DegP in LCFA-utilizing cells. by Kanchan Jaswal (9542107)

“…The band corresponding to AP is shown (Mol. wt. ~50 kDa). <i>(C) Compromised DsbA-DsbB machinery is responsible for the decrease in alkaline phosphatase activity in cells utilizing oleate</i>. …”

Average radiant efficiency (± SEM) in equally sized regions of interest (ROIs) of the non-pregnant uterus. by Kalman F. Szucs (19353218)

“…<p>A significant decrease in αvβ3 integrin was observed in the PET imaging procedure. (***: p < 0.001).…”

Vaginal impedance (± SEM) values measured with the estrus cycle monitor. by Kalman F. Szucs (19353218)

Distribution of hookworm infections in different P/A/Ms in 2019 according to the national surveillance. by Hui-Hui Zhu (6506063)

Stem cell marker expression in TSCs from differently aged mice (2.5m–2.5 months; 5m–5 months; 9m–9 months and 24m–24 months). by Jianying Zhang (256508)

“…<p><b>A–P:</b> Immunocytochemical staining for the indicated stem cell markers was performed using stem cell marker specific antibodies. …”

Effects of cetrorelix treatment on changes in the KCl-evoked contractions of the non-pregnant uterus (U) and the cecum (C). by Kalman F. Szucs (19353218)

Effects of cetrorelix treatment on changes in spontaneous contractions of the non-pregnant uterus (U) and the cecum (C). by Kalman F. Szucs (19353218)

Changes in the power spectrum density maximum values (PsDmax) after cetrorelix treatment in anesthetized rats detected by in vivo smooth muscle electromyography. by Kalman F. Szucs (19353218)

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…We performed exome sequencing of five cases at this stage with no evidence of dysplasia to identify genetic alterations (exon-level copy number alterations, indels, and single nucleotide variants), their association with transcript levels and relationship with oral cancer susceptibility. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…We performed exome sequencing of five cases at this stage with no evidence of dysplasia to identify genetic alterations (exon-level copy number alterations, indels, and single nucleotide variants), their association with transcript levels and relationship with oral cancer susceptibility. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…We performed exome sequencing of five cases at this stage with no evidence of dysplasia to identify genetic alterations (exon-level copy number alterations, indels, and single nucleotide variants), their association with transcript levels and relationship with oral cancer susceptibility. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…We performed exome sequencing of five cases at this stage with no evidence of dysplasia to identify genetic alterations (exon-level copy number alterations, indels, and single nucleotide variants), their association with transcript levels and relationship with oral cancer susceptibility. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…We performed exome sequencing of five cases at this stage with no evidence of dysplasia to identify genetic alterations (exon-level copy number alterations, indels, and single nucleotide variants), their association with transcript levels and relationship with oral cancer susceptibility. …”

Supplementary Material for: Somatic variants and exon-level copy number changes in five hyperplastic-stage oral leukoplakias. by Anne A. (13992672)

“…We performed exome sequencing of five cases at this stage with no evidence of dysplasia to identify genetic alterations (exon-level copy number alterations, indels, and single nucleotide variants), their association with transcript levels and relationship with oral cancer susceptibility. …”